Devices with Pentium components should undergo safety analysis, FDA says.
This article was originally published in The Gray Sheet
Executive Summary
DEVICES WITH PENTIUM CHIP COMPONENTS SHOULD UNDERGO SAFETY ANALYSIS to determine whether device safety and effectiveness could be adversely affected by flaws in Intel Corporation's Pentium computer processors, FDA Center for Devices and Radiological Health Director Bruce Burlington tells device manufacturers in a Feb. 14 letter. The recommendation applies to devices and software accessories that incorporate or can be used on systems that incorporate a Pentium processor.